🇺🇸 FDA
Patent

US 10821078

Nanostructure enhanced targeting (NSET) of inflammatory cells

granted A61KA61K47/34A61K49/0032

Quick answer

US patent 10821078 (Nanostructure enhanced targeting (NSET) of inflammatory cells) held by Northwestern University expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K47/34, A61K49/0032, A61K49/0034, A61K49/0086